We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 7.7%
3 Consumer Discretionary 6.83%
4 Financials 6.52%
5 Industrials 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IHS icon
4726
IHS Holding
IHS
$2.81B
$6K ﹤0.01%
1,039
-1,732
-63% -$10.8K
IIIN icon
4727
Insteel Industries
IIIN
$634M
$6K ﹤0.01%
209
-2,847
-93% -$78K
INUV icon
4728
Inuvo
INUV
$14.2M
$6K ﹤0.01%
2,739
+734
+37% +$2.44K
IONQ icon
4729
IonQ
IONQ
$18.2B
$6K ﹤0.01%
1,630
-24,316
-94% -$117K
IXN icon
4730
iShares Global Tech ETF
IXN
$9.47B
$6K ﹤0.01%
127
-730
-85% -$33.3K
JSPR icon
4731
Jasper Therapeutics
JSPR
$28.7M
$6K ﹤0.01%
1,284
-84
-6% -$562
KITT icon
4732
Nauticus Robotics
KITT
$7.05M
$6K ﹤0.01%
+1
New +$10.5K
MBRX icon
4733
Moleculin Biotech
MBRX
$4.06M
$6K ﹤0.01%
14
-12
-46% -$5.07K
MITQ icon
4734
Moving iMage Technologies
MITQ
$5.56M
$6K ﹤0.01%
5,581
+1,672
+43% +$1.84K
MNSB icon
4735
MainStreet Bancshares
MNSB
$179M
$6K ﹤0.01%
+207
New +$5.58K
MOVE icon
4736
Corvex Inc
MOVE
$308M
$6K ﹤0.01%
+42
New +$9.35K
MXI icon
4737
iShares Global Materials ETF
MXI
$356M
$6K ﹤0.01%
70
+64
+1,067% +$4.9K
MYO icon
4738
Myomo
MYO
$57.8M
$6K ﹤0.01%
11,501
+9,403
+448% +$9.36K
NEXN
4739
Nexxen International
NEXN
$598M
$6K ﹤0.01%
+951
New +$6.95K
NEXT icon
4740
NextDecade
NEXT
$1.8B
$6K ﹤0.01%
1,231
-10,734
-90% -$61.7K
NRC icon
4741
NRC Health Common Stock
NRC
$471M
$6K ﹤0.01%
174
-609
-78% -$23.6K
NTRB icon
4742
Nutriband
NTRB
$38.8M
$6K ﹤0.01%
1,619
+1,435
+780% +$5.67K
NXL icon
4743
Nexalin Technology
NXL
$7.71M
$6K ﹤0.01%
+8,254
New +$12.6K
OPI
4744
DELISTED
Office Properties Income Trust
OPI
$6K ﹤0.01%
437
-4,005
-90% -$57.7K
OPTN
4745
DELISTED
OptiNose
OPTN
$6K ﹤0.01%
200
-301
-60% -$11.4K
OXSQ icon
4746
Oxford Square Capital
OXSQ
$160M
$6K ﹤0.01%
1,822
+287
+19% +$875
PBI icon
4747
Pitney Bowes
PBI
$2.28B
$6K ﹤0.01%
1,578
-13,264
-89% -$44.7K
PERF icon
4748
Perfect Corp
PERF
$191M
$6K ﹤0.01%
+809
New +$5.98K
PEY icon
4749
Invesco High Yield Equity Dividend Achievers ETF
PEY
$1.18B
$6K ﹤0.01%
270
-96,126
-100% -$1.96M
PFI icon
4750
Invesco Dorsey Wright Financial Momentum ETF
PFI
$60.4M
$6K ﹤0.01%
138

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.